ProMED-AMR, a partnership between ISID and Public Health England is set to bolster global AMR surveillance

The International Society for Infectious Diseases’ (ISID) Program for Monitoring Emerging Diseases (ProMED) is announcing its partnership with Public Health England (PHE), on behalf of the UK’s Department of Health and Social Care, to bolster global antimicrobial resistance (AMR) surveillance through technology transfer, monitoring and evaluation, and information exchange.

The widespread use of antimicrobials, (including their overuse in animals and humans), gaps in infection prevention and control, and inadequate disease surveillance diminishes our arsenal of tools to treat and prevent resistant infections.  The goal of the partnership is to improve situational awareness surrounding AMR and empower astute practitioners with useful data.  This formal collaborative project showcases the strength and reach brought together by two leading public health organizations, focusing on lower- and middle-income countries (LMICs).